Clearmind Medicine Inc. (CMND) Form 6-K — Oct 16, 2026
Clearmind Medicine delivered a notice on October 16, 2026 to draw $2.0 million of convertible promissory notes from CLA Investors under its securities purchase agreements, receiving a cash purchase price of $1.8 million, or 90% of principal. The notes are part of a facility allowing up to $10.0 million in aggregate principal, originally dated September 17, 2025 and amended April 30, 2026.
Key figures
- Debt Amount
- 2000000
- Gross Proceeds
- 1800000
- Expected close
- on or before 2026-10-19
- Spa original date
- 2025-09-17
- Spa amendment date
- 2026-04-30
- Max facility principal
- 10000000
- Purchase price percent of principal
- 90
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.